Carsten Flohr

Carsten Flohr publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carsten Flohr sits on this spectrum.

Carsten Flohr D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carsten Flohr sits on this spectrum.

Best Publications

• Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants

  Michael R. Perkin;Kirsty Logan;Anna Tseng;Bunmi Raji

  968
  Citations

• New insights into the epidemiology of childhood atopic dermatitis

  Unknown

  600
  Citations

• The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017.

  Unknown

  523
  Citations

• Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

  Eric L Simpson;Rodney Sinclair;Seth Forman;Andreas Wollenberg

  468
  Citations

• European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

  Unknown

  465
  Citations

• Does atopic dermatitis cause food allergy? A systematic review

  Teresa Tsakok;Tom Marrs;Mahrose Mohsin;Susannah Baron

  444
  Citations

• How epidemiology has challenged 3 prevailing concepts about atopic dermatitis

  Hywel Williams;Carsten Flohr

  423
  Citations

• Does atopic dermatitis cause food allergy? A systematic review.

  Teresa Tsakok;Tom Marrs;Tom Marrs;Mahrose Mohsin;Susannah Baron

  398
  Citations

• How atopic is atopic dermatitis

  Carsten Flohr;S.G.O Johansson;Carl-Fredrik Wahlgren;Hywel Williams

  391
  Citations

• Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).

  Eric L. Simpson;Carsten Flohr;Lawrence F. Eichenfield;Thomas Bieber

  379
  Citations

• Psychological and educational interventions for atopic eczema in children

  Unknown

  369
  Citations

• European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations

  Unknown

  303
  Citations

• Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial

  Joanne R Chalmers;Rachel H Haines;Lucy E Bradshaw;Alan A Montgomery

  299
  Citations

• Atopic dermatitis: the skin barrier and beyond

  T. Tsakok;R. Woolf;C.H. Smith;S. Weidinger

  297
  Citations

• Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age.

  Carsten Flohr;Carsten Flohr;Kirsty England;Suzana Radulovic;W. H. I. McLean

  296
  Citations

• Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?

  C. Flohr;D. Pascoe;H.C. Williams

  281
  Citations

• Research needs in allergy: an EAACI position paper, in collaboration with EFA

  Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  265
  Citations

• Research Techniques Made Simple: Transepidermal Water Loss Measurement as a Research Tool

  Unknown

  257
  Citations

• Do helminth parasites protect against atopy and allergic disease

  C. Flohr;R. J. Quinnell;J. Britton

  250
  Citations

• When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

  Eric L. Simpson;Marjolein Bruin-Weller;Carsten Flohr;Michael R. Ardern-Jones

  249
  Citations